Josep Domingo-Domenech Department of Pathology Icahn School of Medicine at Mount Sinai Biography Publications Institution JoVE Articles Josep Domingo-Domenech has not added a biography. If you are Josep Domingo-Domenech and would like to personalize this page please email our Author Liaison for assistance. Publications Targeting Sarcoma Tumor-initiating Cells Through Differentiation Therapy Stem Cell Research. May, 2017 | Pubmed ID: 28433655 The Role of GATA2 in Lethal Prostate Cancer Aggressiveness Nature Reviews. Urology. Jan, 2017 | Pubmed ID: 27872477 Tumour Initiating Cells and IGF/FGF Signalling Contribute to Sorafenib Resistance in Hepatocellular Carcinoma Gut. Mar, 2017 | Pubmed ID: 26658144 Definitive Management of Primary Bladder Tumors in the Context of Metastatic Disease: Who, How, When, and Why? Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Oct, 2016 | Pubmed ID: 27551117 Enrichment of Cells with Cancer Stem Cell-Like Markers in Relapses of Chemoresistant Patients with Locally Advanced Head and Neck Squamous Cell Carcinoma Oncology. 2016 | Pubmed ID: 27077749 A Targetable GATA2-IGF2 Axis Confers Aggressiveness in Lethal Prostate Cancer Cancer Cell. Feb, 2015 | Pubmed ID: 25670080 Advances in the Management of Muscle-invasive Bladder Cancer Through Risk Prediction, Risk Communication, and Novel Treatment Approaches Clinical Advances in Hematology & Oncology : H&O. Feb, 2013 | Pubmed ID: 23598909 A Common MicroRNA Signature Consisting of MiR-133a, MiR-139-3p, and MiR-142-3p Clusters Bladder Carcinoma in Situ with Normal Umbrella Cells The American Journal of Pathology. Apr, 2013 | Pubmed ID: 23410519 Suppression of Acquired Docetaxel Resistance in Prostate Cancer Through Depletion of Notch- and Hedgehog-dependent Tumor-initiating Cells Cancer Cell. Sep, 2012 | Pubmed ID: 22975379 A BAC-based Transgenic Mouse Specifically Expresses an Inducible Cre in the Urothelium PloS One. 2012 | Pubmed ID: 22496911 PAX7-FKHR Fusion Gene Inhibits Myogenic Differentiation Via NF-kappaB Upregulation Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Mar, 2012 | Pubmed ID: 22374423 Anatomical Features of the Urethra and Urinary Bladder Catheterization in Female Mice and Rats. An Essential Translational Tool Acta Cirúrgica Brasileira / Sociedade Brasileira Para Desenvolvimento Pesquisa Em Cirurgia. 2011 | Pubmed ID: 22030824 Predictive Value of Microtubule Associated Proteins Tau and Stathmin in Patients with Nonmuscle Invasive Bladder Cancer Receiving Adjuvant Intravesical Taxane Therapy The Journal of Urology. Nov, 2011 | Pubmed ID: 21944130 Distinct Expression Profiles of P63 Variants During Urothelial Development and Bladder Cancer Progression The American Journal of Pathology. Mar, 2011 | Pubmed ID: 21356385 Molecular Pathways of Urothelial Development and Bladder Tumorigenesis Urologic Oncology. Jul-Aug, 2010 | Pubmed ID: 20610278 Loco-regional Control After Postoperative Radiotherapy for Patients with Regional Nodal Metastases from Melanoma Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Oct, 2009 | Pubmed ID: 19828412 Inactivation of NF-kappaB by Proteasome Inhibition Contributes to Increased Apoptosis Induced by Histone Deacetylase Inhibitors in Human Breast Cancer Cells Breast Cancer Research and Treatment. Nov, 2008 | Pubmed ID: 18064564 Prognostic Implications of Protein S-100beta Serum Levels in the Clinical Outcome of High-risk Melanoma Patients Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine. 2007 | Pubmed ID: 17962723 Toxicity of Combined Treatment of Adjuvant Irradiation and Interferon Alpha2b in High-risk Melanoma Patients Melanoma Research. Oct, 2007 | Pubmed ID: 17885585 Clinical Outcome After Surgical Resection of Lung Metastases from Melanoma Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Jan, 2007 | Pubmed ID: 17272230 Interleukin 6, a Nuclear Factor-kappaB Target, Predicts Resistance to Docetaxel in Hormone-independent Prostate Cancer and Nuclear Factor-kappaB Inhibition by PS-1145 Enhances Docetaxel Antitumor Activity Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2006 | Pubmed ID: 17000695 Whole Brain Irradiation and Temozolomide Based Chemotherapy in Melanoma Brain Metastases Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. Apr, 2006 | Pubmed ID: 16648102 Differential Cellular and Molecular Effects of Bortezomib, a Proteasome Inhibitor, in Human Breast Cancer Cells Molecular Cancer Therapeutics. Mar, 2006 | Pubmed ID: 16546981 Low Thymidylate Synthase Expression in the Primary Tumor Predicts Favorable Clinical Outcome in Resected Gastric Cancer Patients Treated with Adjuvant Tegafur Oncology. 2004 | Pubmed ID: 15218314 [Fulminant Hepatic Failure As Form of Presentation of a Peripheral T Cell Lymphoma] Medicina Clínica. Nov, 2002 | Pubmed ID: 12459111 Isolamento e caratterizzazione delle cellule che invitano il tumore dalle cellule che hanno invitato il tumore da Sarcoma Xenotrapianto derivato dal paziente Dan Han1, Veronica Rodriguez-Bravo1, Sudeh Izadmehr1, Josep Domingo-Domenech1, Carlos Cordon-Cardo1 1Department of Pathology, Icahn School of Medicine at Mount Sinai JoVE 57011 Cancer Research Generazione di modelli cellulari del carcinoma della prostata di resistenza per il Docetaxel agente anti-mitotico Lisa Mohr1, Marc Carceles-Cordon1, Jungreem Woo1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1, Veronica Rodriguez-Bravo1,2 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai JoVE 56327 Cancer Research Generazione di cancro alla prostata del paziente Derivato modelli di xenotrapianto di cellule tumorali circolanti Estrelania S. Williams1, Veronica Rodriguez-Bravo3, Uma Chippada-Venkata2, Janis De Ia Iglesia-Vicente1, Yixuan Gong2, Matthew Galsky2, William Oh2, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 3Molecular Biology Program, Memorial Sloan-Kettering Cancer Center Medicine Isolamento di cancro cellule staminali da campioni umani di cancro alla prostata Samuel J. Vidal1, S. Aidan Quinn1, Janis de la Iglesia-Vicente1, Dennis M. Bonal1, Veronica Rodriguez-Bravo2, Adolfo Firpo-Betancourt1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Icahn School of Medicine at Mount Sinai, 2Molecular Biology Program, Memorial Sloan-Kettering Cancer Center JoVE 51332 Medicine
Isolamento e caratterizzazione delle cellule che invitano il tumore dalle cellule che hanno invitato il tumore da Sarcoma Xenotrapianto derivato dal paziente Dan Han1, Veronica Rodriguez-Bravo1, Sudeh Izadmehr1, Josep Domingo-Domenech1, Carlos Cordon-Cardo1 1Department of Pathology, Icahn School of Medicine at Mount Sinai JoVE 57011 Cancer Research
Generazione di modelli cellulari del carcinoma della prostata di resistenza per il Docetaxel agente anti-mitotico Lisa Mohr1, Marc Carceles-Cordon1, Jungreem Woo1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1, Veronica Rodriguez-Bravo1,2 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai JoVE 56327 Cancer Research
Generazione di cancro alla prostata del paziente Derivato modelli di xenotrapianto di cellule tumorali circolanti Estrelania S. Williams1, Veronica Rodriguez-Bravo3, Uma Chippada-Venkata2, Janis De Ia Iglesia-Vicente1, Yixuan Gong2, Matthew Galsky2, William Oh2, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 2Department of Hematology/Oncology, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, 3Molecular Biology Program, Memorial Sloan-Kettering Cancer Center Medicine
Isolamento di cancro cellule staminali da campioni umani di cancro alla prostata Samuel J. Vidal1, S. Aidan Quinn1, Janis de la Iglesia-Vicente1, Dennis M. Bonal1, Veronica Rodriguez-Bravo2, Adolfo Firpo-Betancourt1, Carlos Cordon-Cardo1, Josep Domingo-Domenech1 1Department of Pathology, Icahn School of Medicine at Mount Sinai, 2Molecular Biology Program, Memorial Sloan-Kettering Cancer Center JoVE 51332 Medicine
